The first results from a trial of a candidate Ebola vaccine at Oxford University in the United Kingdom suggests the vaccine has an acceptable safety profile at the doses tested, and is able to generate an immune response.
"The vaccine was well tolerated. Its safety profile is pretty much as we had hoped," said Professor Adrian Hill of the university's Jenner Institute, who led the trial.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article